Inclusion of Human Chorionic Gonadotropin in the Family of Therapeutic Glycoproteins

Journal Title: Women's Health – Open Journal - Year 2017, Vol 3, Issue 1

Abstract

The family of therapeutic glycoproteins contains many members. Some of them have become valuable therapeutic agents in saving the countless number of human lives from some of the most dreadful diseases. They are increasingly taking a center stage among biotherapeutics. The technologies of glycoengineering are making a further impact by modifying the glycan moieties, which make them biologically more active and increase their effectiveness and pharmacokinetics, etc. Human Chorionic Gonadotropin (hCG) has been used in reproductive medicine for the last several decades. The paradigm shift on the hCG actions has created additional therapeutic opportunities against many menacing and dangerous diseases that are no less important than the ones treated by some of the prominent members of the therapeutic glycoproteins family. However, to the best of the authors’ knowledge, hCG has never been included in this family or tapped the potential of glycoengineering to make hCG even more therapeutically effective than the currently used preparations. It is time to include hCG in the family and begin glycoengineering on recombinant hormone.

Authors and Affiliations

C. V. Rao

Keywords

Related Articles

Inclusion of Human Chorionic Gonadotropin in the Family of Therapeutic Glycoproteins

The family of therapeutic glycoproteins contains many members. Some of them have become valuable therapeutic agents in saving the countless number of human lives from some of the most dreadful diseases. They are increasi...

Endometriosis and Epigenetics: What do we Know?

Objective Endometriosis is a common gynecological condition with a pathogenesis that is multifactorial and not well understood. The aim of this review was to explore the multiplicity of epigenetic changes in the field of...

Hormone Replacement Therapy and its Risks and Benefits for Women

There is no doubt that as both women and men age, the decline in the hormones which in their earlier years kept them vigorous and youthful has impacted dramatically on their health. Hormonal balance plays an integral rol...

From Menstruation to Menopause: Have We Medicalised the Physiology of Normalcy? (Part 1)

UNDERSTANDING THE RELATIONSHIP BETWEEN MENSTRUATION AND MENOPAUSE Although, there are exceptions to the rule, women generally experience ‘menopause’ between the ages of 48 to 54, within which time the cessation of all me...

University Men’s Perceptions of Emergency Contraception

Objective: Current research on emergency contraceptive needs and usage is centered on females’ experiences and perspectives. The purpose of this study is to gain more insight into men’s understanding of Emergency Contrac...

Download PDF file
  • EP ID EP554903
  • DOI 10.17140/WHOJ-3-119
  • Views 145
  • Downloads 0

How To Cite

C. V. Rao (2017). Inclusion of Human Chorionic Gonadotropin in the Family of Therapeutic Glycoproteins. Women's Health – Open Journal, 3(1), 30-35. https://www.europub.co.uk/articles/-A-554903